CD226 and neoplasm: Taken together, the data published so far demonstrate that CD155 induces an imbalance of TIGIT and DNAM-1 expression in the tumour microenvironment, further suppressing T-cell and NK cell activity, consequently promoting tumour growth and metastasis.